A Double-blind, Randomized, Parallel Group Study to Compare the Efficacy and Safety, of Oxycodone Immediate-release Capsules Versus Morphine Immediate-release Tablets in Hospitalized Patients With Moderate to Severe Pain Following Surgery.
OxyNorm Capsules
+ Morphine tablet
Manifestations Neurologiques+4
+ Douleur
+ Processus pathologiques
Étude thérapeutique
Résumé
Date de début de l'étude : 1 juillet 2011
Date à laquelle le premier participant a commencé l'étude.To evaluate the efficacy and safety of oxycodone immediate-release capsules compared with morphine immediate-release tablets in hospitalized patients with moderate to severe pain following surgery.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.240 participants à inclure
Nombre total de participants que l'essai clinique vise à recruter.Traitement
Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.De 18 à 65 ans
Tranche d'âge des participants éligibles à participer.Volontaires sains non autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Conditions
Pathologie
Critères
Inclusion Criteria: Patients of either sex aged 18 to 80 years inclusive. Patients who have given written informed consent to participate in the study. Able and willing to communicate with the investigator and his/her staff. Free of anesthesia as assessed through question and answer interaction with nurse at which time oral medication is indicated. Reporting "moderate" or "severe" pain (VAS ≥ 4) related to surgery and requesting analgesics for pain relief. Exclusion Criteria: Patients have developed tolerance to or dependence on narcotic analgesics and/or alcohol. Patients with ASA ≥ 3 . Have any concomitant medical condition that would be adversely affected by analgesics or confound the quantification of analgesia, or could affect the absorption, metabolism or excretion of the study drugs in any clinically significant fashion. Have known hypersensitivity to any of the study medications or related agents. Have taken analgesic medications within three hours (wash-out) prior to dosing. Have developed complications from the surgical procedure that would confound the study. Have a history of severe iatrogenic adverse experiences. Mothers nursing their infant during the 24 hours following study drug administration, or pregnant women. Patient with Nothing Per Os (NPO) as stated in patient's chart or physician's order. Surgery in patients with epidural anesthesia Patients with Severe impairment of liver at preoperative stage (ALT, AST ≥ 1.5 times upper limit) and abnormal renal function. Patients with medical history of recovering from abnormal surgery anesthesia. Patients with medical history of hypertension (Systolic blood pressure ≥ 180Hg, Diastolic blood pressure 110Hg). Patients with shock. Patients with COPD. According to investigator to determine, patients are in addition the inclusion criteria and exclusion criteria for any other reason than not suitable in this study.
Plan de l'étude
Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.2 groupes d'intervention sont désignés dans cette étude
Cette étude ne comporte pas de groupe placebo.
Groupes de traitement
Groupe I
ExpérimentalGroupe II
Comparateur actifObjectifs de l'étude
Objectifs principaux
Objectifs secondaires